Evidence	O
that	O
breast	O
cancer	O
risk	O
at	O
the	O
2q35	O
locus	O
is	O
mediated	O
through	O
IGFBP5	O
regulation	O
.	O


GWAS	O
have	O
identified	O
a	O
breast	O
cancer	O
susceptibility	O
locus	O
on	O
2q35	O
.	O


Here	O
we	O
report	O
the	O
fine	O
mapping	O
of	O
this	O
locus	O
using	O
data	O
from	O
101	O
,	O
943	O
subjects	O
from	O
50	O
case	O
-	O
control	O
studies	O
.	O


We	O
genotype	O
276	O
SNPs	O
using	O
the	O
'	O
iCOGS	O
'	O
genotyping	O
array	O
and	O
impute	O
genotypes	O
for	O
a	O
further	O
1	O
,	O
284	O
using	O
1000	O
Genomes	O
Project	O
data	O
.	O


All	O
but	O
two	O
,	O
strongly	O
correlated	O
SNPs	O
(	O
rs4442975	O
G	O
/	O
T	O
and	O
rs6721996	O
G	O
/	O
A	O
)	O
are	O
excluded	O
as	O
candidate	O
causal	O
variants	O
at	O
odds	O
against	O
>	O
100	O
:	O
1	O
.	O


The	O
best	O
functional	O
candidate	O
,	O
rs4442975	O
,	O
is	O
associated	O
with	O
oestrogen	O
receptor	O
positive	O
(	O
ER	O
+	O
)	O
disease	O
with	O
an	O
odds	O
ratio	O
(	O
OR	O
)	O
in	O
Europeans	O
of	O
0	O
.	O
85	O
(	O
95	O
%	O
confidence	O
interval	O
=	O
0	O
.	O
84	O
-	O
0	O
.	O
87	O
;	O
P	O
=	O
1	O
.	O
7	O
x	O
10	O
(	O
-	O
43	O
)	O
)	O
per	O
t	O
-	O
allele	O
.	O


This	O
SNP	O
flanks	O
a	O
transcriptional	O
enhancer	O
that	O
physically	O
interacts	O
with	O
the	O
promoter	B-PROMOTER
of	I-PROMOTER
IGFBP5	E-PROMOTER
(	O
encoding	O
insulin	O
-	O
like	O
growth	O
factor	O
-	O
binding	O
protein	O
5	O
)	O
and	O
displays	O
allele	O
-	O
specific	O
gene	O
expression	O
,	O
FOXA1	O
binding	O
and	O
chromatin	O
looping	O
.	O


Evidence	O
suggests	O
that	O
the	O
g	O
-	O
allele	O
confers	O
increased	O
breast	O
cancer	O
susceptibility	O
through	O
relative	O
downregulation	O
of	O
IGFBP5	O
,	O
a	O
gene	O
with	O
known	O
roles	O
in	O
breast	O
cell	O
biology	O
.	O
